<p>BALB/c mice were administered AcHERV-triHPV or PBS (control) three times over a 2-week interval via the SL or IM route. Mice were sublingually immunized with three different doses of AcHERV-triHPV (1×10<sup>8</sup>, 1×10<sup>9</sup>, and 1×10<sup>10</sup> copies per mouse) or were immunized intramuscularly with 1×10<sup>9</sup> copies per mouse. Samples were collected 2, 4, and 6 weeks after the first immunization. Antigen-specific serum IgG antibody titers against HPV16L1 (A), HPV18L1 (B), and HPV58L1 (C) were determined by ELISA. *P < 0.05 compared with other groups (ANOVA and Student-Newman-Keuls test).</p
<p>(A) Anti-HPV16 L1 IgG titers and (B) neutralizing activities against HPV16 PsVs in mouse sera imm...
<p>Mice were administered PBS (Control), ITIV (0.5 μg A/H1N, A/H3N2, and B HA/mouse; Vaccine), ITIV ...
<p>Balb/c mice were vaccinated i.m. three times at two week intervals with a mixture of L1 vectors o...
<p>Mice were administered AcHERV-triHPV or PBS (control) three times over a 2-week interval by the S...
<p>BALB/c mice were intramuscularly injected with PBS or 1×10<sup>7</sup> PFU of AcHERV-based nanova...
<p>BALB/c mice were intramuscularly immunized with Cervarix, PBS (control), or 1×10<sup>7</sup> PFU ...
<p>The anti-HPV16 L1 IgG and anti-HPV16 neutralizing antibody titers of the PBS-, hHPV16 VLP- and cH...
<p>Mice were immunized according to immunization protocol-1 (<a href="http://www.plosone.org/article...
<p>C57BL/6 mice (5 per group) vaccinated twice intramuscularly with AAVLP(HPV16/31L2) particles eith...
<p>Mice were immunized three times with PBS (A, B, C), AcHERV-HP16L1 (D), AcHERV-HP18L1 (E), AcHERV-...
<p>BALB/c mice were intramuscularly injected with PBS or 1×10<sup>7</sup> PFU of AcHERV-based nanova...
<p>(A) Regimen of prime and boost vaccination was followed by viral challenge. IM0, IM1, and IM2 rep...
<p>Balb/c mice were vaccinated i.m. with electroporation three times at two week intervals with 20 µ...
<p>Mice were immunized with low dose of AAVLP(HPV16/31L2) particles either twice (LD+M 2x) or three ...
<p>Serum was sampled at 1 to 20 weeks after immunization with recombinant baculoviruses, Cervarix, o...
<p>(A) Anti-HPV16 L1 IgG titers and (B) neutralizing activities against HPV16 PsVs in mouse sera imm...
<p>Mice were administered PBS (Control), ITIV (0.5 μg A/H1N, A/H3N2, and B HA/mouse; Vaccine), ITIV ...
<p>Balb/c mice were vaccinated i.m. three times at two week intervals with a mixture of L1 vectors o...
<p>Mice were administered AcHERV-triHPV or PBS (control) three times over a 2-week interval by the S...
<p>BALB/c mice were intramuscularly injected with PBS or 1×10<sup>7</sup> PFU of AcHERV-based nanova...
<p>BALB/c mice were intramuscularly immunized with Cervarix, PBS (control), or 1×10<sup>7</sup> PFU ...
<p>The anti-HPV16 L1 IgG and anti-HPV16 neutralizing antibody titers of the PBS-, hHPV16 VLP- and cH...
<p>Mice were immunized according to immunization protocol-1 (<a href="http://www.plosone.org/article...
<p>C57BL/6 mice (5 per group) vaccinated twice intramuscularly with AAVLP(HPV16/31L2) particles eith...
<p>Mice were immunized three times with PBS (A, B, C), AcHERV-HP16L1 (D), AcHERV-HP18L1 (E), AcHERV-...
<p>BALB/c mice were intramuscularly injected with PBS or 1×10<sup>7</sup> PFU of AcHERV-based nanova...
<p>(A) Regimen of prime and boost vaccination was followed by viral challenge. IM0, IM1, and IM2 rep...
<p>Balb/c mice were vaccinated i.m. with electroporation three times at two week intervals with 20 µ...
<p>Mice were immunized with low dose of AAVLP(HPV16/31L2) particles either twice (LD+M 2x) or three ...
<p>Serum was sampled at 1 to 20 weeks after immunization with recombinant baculoviruses, Cervarix, o...
<p>(A) Anti-HPV16 L1 IgG titers and (B) neutralizing activities against HPV16 PsVs in mouse sera imm...
<p>Mice were administered PBS (Control), ITIV (0.5 μg A/H1N, A/H3N2, and B HA/mouse; Vaccine), ITIV ...
<p>Balb/c mice were vaccinated i.m. three times at two week intervals with a mixture of L1 vectors o...